SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : XOMA. Bull or Bear?
XOMA 33.53-2.8%Nov 12 3:59 PM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Robert K. who wrote (17056)7/12/2004 12:58:34 AM
From: Bluegreen   of 17367
 
Bob, no not WMB but Neuprex and Baxter history. History of not letting Girior in on final FDA decision. After the sell programs are done for management I don't see any incentive for them and Wall street as George says not to restructure. Just look at their burn rate and stock price. Better off now? What kind of a joke is that??? Now all you have is small piece of net of a product that has just had a stinker of a quarter!!!! This Raptiva turkey can't even get off the ground with spending of around 20 million a quarter and all those sales reps!!!! Even Genentech touts time and time again the Enbrel competition. They are almost GIDDY in describing the big threat to sales from Enbrel on their conference calls. I once knew Neuprex and Raptiva is NO Neuprex. Also look at the amount of common shares now compared to a few years ago. Besides what is so bad about a restructure? Wall street wins, after the sell programs for management are done management and the company will win, the only losers will be the moronic shareholders that didn't get out in time. I say moronic shareholders because those SELL programs put in place by management are an instrument to distance management from the current common shares. GOOD LUCK!!!!
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News